GRAFTYS DISCOVERY

Founded in 2005 and based on the research works of Pr. Jean-Michel Bouler (CEISAM/CNRS), Graftys develops, manufactures and markets patented synthetic orthopedic biomaterials, in particular new generations of resorbable calcium-phosphate cements, for reconstructive orthopedic surgery. Within the 3 million annual procedures bone graft market, the bone cement market segment is one of the fastest-growing. The Company’s key products – Graftys® Quickset fast setting/high viscosity and Graftys® HBS lower viscosity/high injectability cements – are commercialized in more than 25 countries, including Europe and the United States of America, through distribution partnerships.